Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities
Get it wrong, and you are either underdosing yourself or, worse, taking double what you should
Consult with experienced peptide specialists Customized peptide recommendations for your needs Continuous guidance throughout your peptide journey
While semaglutide can be a useful tool in promoting weight loss, it is not a standalone solution
Multi-joint exercises like squats, lunges, and push-ups signal your body to hold on to muscle mass by showing its still needed
These decisions should be individualized based on your health needs and breastfeeding goals